ArticleAmerican journal of hematology2024
White blood cell count levels are associated with inflammatory response and constitute independent outcome predictors in adult patients with acute myeloid leukemia aged <60 years.
Abstract read
In one paragraph
Article in American journal of hematology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Michael OzgaThe Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.ORCID 0000-0002-7361-9846
Deedra NicoletClara D. Bloomfield Center for Leukemia Outcomes Research, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.
Krzysztof MrózekThe Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.ORCID 0000-0002-1408-5063
Christopher J WalkerThe Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.
James S BlachlyThe Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.ORCID 0000-0002-4275-5562
Jessica KohlschmidtClara D. Bloomfield Center for Leukemia Outcomes Research, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.
Shelley OrwickThe Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.
Andrew J CarrollDepartment of Genetics, University of Alabama-Birmingham, Birmingham, Alabama, USA.
Richard A LarsonDepartment of Medicine, University of Chicago, Chicago, Illinois, USA.
Jonathan E KolitzMonter Cancer Center, Hofstra Northwell School of Medicine, Lake Success, New York, USA.
Bayard L PowellWake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina, USA.
Richard M StoneDepartment of Medical Oncology, Dana-Farber/Partners Cancer Care, Harvard University, Boston, Massachusetts, USA.
John C ByrdDepartment of Internal Medicine, University of Cincinnati, Cincinnati, Ohio, USA.
Ann-Kathrin EisfeldClara D. Bloomfield Center for Leukemia Outcomes Research, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.
Alice S MimsThe Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.
Funding
Member Site CoreU10CA180821 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI Evanthia Galanis · 2014 to 2026
$177.3MTranslational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Jennifer A. Woyach · 1985 to 2026
$132.3MStatistics CoreU10CA180882 · NCI · MAYO CLINIC ROCHESTER · PI Sumithra Jay Mandrekar · 2014 to 2026
$115.0MWake Forest NCORP Research BaseUG1CA189824 · NCI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Emily Van Meter Dressler, GLENN J LESSER · 2014 to 2026
$57.9MTHE ALLIANCE NCTN BIOREPOSITORY AND BIOSPECIMEN RESOURCEU24CA196171 · NCI · WASHINGTON UNIVERSITY · PI Mine Cicek, Wendy Frankel · 2015 to 2026
$35.0MPROVIDE STATISTICAL SERVICESU10CA023318 · NCI · DANA-FARBER CANCER INSTITUTE · PI GRAY, ROBERT J · 1985 to 2013
$33.4MNorthwell Health NCORPUG1CA189850 · NCI · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI VINCENT P VINCIGUERRA · 2014 to 2026
$13.3MSPORE Leukemia Tissue BankP50CA140158 · NCI · OHIO STATE UNIVERSITY · PI MARCUCCI, GUIDO · 2009 to 2013
$11.2MOSU as a Network Lead Academic Participating Site for the NCI NCTNUG1CA233331 · NCI · OHIO STATE UNIVERSITY · PI John L. Hays, Dwight H. Owen · 2019 to 2026
$8.9MNCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer CareUG1CA233180 · NCI · DANA-FARBER CANCER INST · PI Harold John Burstein · 2019 to 2026
$8.6MTargeted Therapy for LeukemiaR35CA197734 · NCI · UNIVERSITY OF CINCINNATI · PI BYRD, JOHN C. · 2015 to 2021
$6.6MNCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer CareU10CA180867 · NCI · DANA-FARBER CANCER INST · PI BURSTEIN, HAROLD JOHN, KIBEL, ADAM S · 2014 to 2018
$6.2MAmerican Cancer SocietyColeman Leukemia Research FoundationD Warren Brown FoundationLeukemia & Lymphoma Society Translational Research GrantLeukemia Research FoundationNational Cancer Institute of the National Institutes of Health 5P30CA016058National Cancer Institute of the National Institutes of Health R01CA262496National Cancer Institute of the National Institutes of Health R01CA283574-01National Cancer Institute of the National Institutes of Health R01CA284595-01National Cancer Institute of the National Institutes of Health R35CA197734National Cancer Institute of the National Institutes of Health U10CA140158National Cancer Institute of the National Institutes of Health U10CA180821National Cancer Institute of the National Institutes of Health U10CA180867National Cancer Institute of the National Institutes of Health U10CA180882National Cancer Institute of the National Institutes of Health U24CA196171National Cancer Institute of the National Institutes of Health UG1CA189824National Cancer Institute of the National Institutes of Health UG1CA18985National Cancer Institute of the National Institutes of Health UG1CA189850National Cancer Institute of the National Institutes of Health UG1CA23318National Cancer Institute of the National Institutes of Health UG1CA233247National Cancer Institute of the National Institutes of Health UG1CA233253National Cancer Institute of the National Institutes of Health UG1CA233331National Cancer Institute of the National Institutes of Health UG1CA233338National Cancer Institute of the National Institutes of Health UG1CA283338NCI NIH HHS P30 CA016058NCI NIH HHS P50 CA140158NCI NIH HHS R01 CA262496NCI NIH HHS R01 CA283574NCI NIH HHS R01 CA284595NCI NIH HHS R35 CA197734NCI NIH HHS U10 CA023318NCI NIH HHS U10 CA180821NCI NIH HHS U10 CA180867NCI NIH HHS U10 CA180882NCI NIH HHS U24 CA196171NCI NIH HHS UG1 CA189824NCI NIH HHS UG1 CA189850NCI NIH HHS UG1 CA233180NCI NIH HHS UG1 CA233247NCI NIH HHS UG1 CA233253NCI NIH HHS UG1 CA233328NCI NIH HHS UG1 CA233331NCI NIH HHS UG1 CA233338Ohio Supercomputer Center and Shared Resources (Leukemia Tissue Bank)Pelotonia Fellowship Program
Abstract
PubMed holds no abstract for this paper.
Indexed as
InflammationLeukemia, Myeloid, AcuteAdultAge FactorsFemaleHumansLeukocyte CountMaleMiddle AgedPrognosisRetrospective StudiesTreatment OutcomeYoung Adult
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.